The North America continuous glucose monitoring (CGM) market is undergoing rapid expansion, driven by the increasing prevalence of diabetes, the need for real-time glucose tracking, and the integration of innovative healthcare technologies. According to Expert Market Research, the market reached a valuation of USD 6.56 billion in 2024. It is expected to grow at a CAGR of 14.50% from 2025–2034 to attain a market size of USD 25.41 billion by 2034.

North America Continuous Glucose Monitoring Market Size

The escalating number of diabetes cases across North America, particularly in the United States and Canada, is a major contributor to the expanding CGM market. Advances in sensor technology, miniaturization, and mobile connectivity have positioned CGM systems as critical tools in diabetes care.

CGM devices, which provide continuous, real-time readings of interstitial glucose levels, offer patients and clinicians a powerful tool for maintaining optimal glycemic control. These systems are gaining popularity among Type 1 and Type 2 diabetes patients alike, helping reduce hypoglycemic events and improve long-term health outcomes.

North America Continuous Glucose Monitoring Market Share

Among product components, sensors hold the largest market share due to their high usage frequency and critical role in glucose detection. Sensors are typically replaced every 7 to 14 days, contributing significantly to recurring revenue.

Abbott and Dexcom, Inc. lead the North American CGM market, offering widely adopted systems such as the FreeStyle Libre and Dexcom G6/G7, respectively. Medtronic PLC remains a strong player with its integrated insulin pump-CGM hybrid systems. These companies dominate due to their advanced technologies, regulatory approvals, and strong distribution networks.

Geographically, the United States commands the lion’s share of the market, supported by a large patient base, healthcare awareness, insurance coverage, and strong product availability. Canada shows steady growth, backed by increasing diabetes awareness and government initiatives for digital health adoption.

North America Continuous Glucose Monitoring Market Growth & Trends

Several key trends and growth drivers are shaping the North American CGM market:

• Rising Diabetes Prevalence: As per the Centers for Disease Control and Prevention (CDC), over 11% of the U.S. population has diabetes. This creates consistent demand for effective monitoring tools.

• Shift Toward Wearable Technology: Consumer preference for discreet, easy-to-use wearable devices is influencing the design and adoption of CGMs that integrate with smartphones and smartwatches.

• Favorable Reimbursement Policies: Medicare and private insurance plans increasingly cover CGM systems, encouraging broader access.

• Home Healthcare Expansion: Post-pandemic healthcare delivery has shifted toward remote monitoring, benefiting CGM adoption for at-home care management.

• Artificial Intelligence Integration: AI-powered analytics are being incorporated into CGM platforms to deliver predictive alerts and personalized treatment insights.

North America Continuous Glucose Monitoring Market Case Studies & News

Recent developments in the industry reflect a strong focus on innovation and accessibility:

• Dexcom’s G7 Rollout: Dexcom launched its next-gen G7 system, featuring a 60% smaller sensor, faster warm-up, and direct smartphone integration—well received by both adults and pediatric patients.

• Abbott’s Libre 3 FDA Clearance: Abbott’s FreeStyle Libre 3, offering real-time glucose readings every minute without scanning, received U.S. FDA approval, reinforcing its market leadership.

• Senseonics’ Eversense E3: Senseonics introduced an implantable CGM lasting up to 180 days, reducing the burden of frequent sensor replacement.

Strategic partnerships—such as Medtronic’s collaborations with digital health platforms—are aimed at delivering integrated solutions that combine CGM data with telehealth and EMR systems.

North America Continuous Glucose Monitoring Market Analysis

The CGM market in North America is characterized by technological sophistication, a consolidated competitive landscape, and evolving regulatory standards. Factors influencing market dynamics include:

• Regulatory Frameworks: Approval processes by the FDA and Health Canada remain central to market entry.

• Cost and Accessibility: Price sensitivity and insurance coverage remain pivotal to adoption, especially in lower-income demographics.

• Consumer Trust in Digital Health: Growing trust in data-driven care tools is improving the acceptance of CGM systems among patients and clinicians.

Increasing investment in R&D, supportive government policies, and the shift towards value-based care models are expected to sustain market momentum.

North America Continuous Glucose Monitoring Market Segmentation

By Component:

• Sensors – Highest revenue contributor due to frequent replacements and essential functionality.

• Transmitters – Relay data from sensors to display interfaces.

• Receivers – Capture and present glucose data, often integrated with smartphones or wearables.

By Application:

• Type 1 Diabetes – Core user base due to dependence on continuous monitoring.

• Type 2 Diabetes – Growing segment as CGM benefits gain recognition.

• Others – Includes gestational diabetes and prediabetes monitoring.

By Age Group:

• Adult Population – Largest user group, particularly those managing Type 2 diabetes.

• Child Population – Rising demand with FDA approvals for pediatric CGM usage and parent-tracking features.

By End User:

• Hospitals & Clinics – Used for acute care, diagnosis, and treatment planning.

• Home Healthcare – Fastest-growing segment, driven by remote monitoring tools.

• Others – Sports performance and wellness management are emerging applications.

By Country:

• United States – Dominates with high awareness, market penetration, and innovation pipelines.

• Canada – Shows positive outlook with supportive public health programs and policy frameworks.

North America Continuous Glucose Monitoring Market Key Players

Major players in the North America continuous glucose monitoring market include:

• Abbott

• Dexcom, Inc.

• Medtronic PLC

• Senseonics, Inc.

• Byram Healthcare Centers, Inc.

• Hoffmann-La Roche Limited

These companies are investing heavily in innovation, AI integration, user-centric design, and strategic collaborations to sustain competitive advantage and meet evolving patient needs.

View More Reports

Nanopore Sequencing Market

Osteoporosis Drug Pipeline Analysis Report

India Disposable Medical Gloves Market

CDMO Market Size

About Us:

Expert Market Research is a leading market research firm delivering data-driven insights to the pharmaceutical, biotechnology, and medical device industries. Our comprehensive research solutions include market research reports, providing in-depth analysis of industry trends and competitive landscapes; drug pipeline reports, tracking drug development progress, clinical trials, and regulatory approvals; epidemiology reports, offering detailed disease prevalence and patient population studies; and patent reports, assessing intellectual property landscapes and innovation trends, among others.

Leveraging proprietary data, advanced analytics, and expert methodologies, we help businesses navigate complex markets, optimize strategies, and drive innovation. We empower clients with actionable intelligence, enabling them to make informed decisions and stay ahead in the rapidly evolving healthcare sector.

Media Contact:

Company Name: Claight Corporation
Contact Person: Roshan Kumar, Digital Marketing
Email: sales@expertmarketresearch.com
Toll-Free Number: US +1-415-325-5166 | UK +44-702-402-5790
Address: 30 North Gould Street, Sheridan, WY 82801, USA
Website: www.expertmarketresearch.com